{
  "id": 146,
  "text": "The palliative care specialist should be actively involved.Palliative taxane/platinum combination chemotherapy with/without bevacizumab is the preferred option.There is currently no standard second-line chemotherapy, and such patients should be considered for clinical trials.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The palliative care specialist should be actively involved.Palliative taxane/platinum combination chemotherapy with/without bevacizumab is the preferred option.There is currently no standard second-line chemotherapy, and such patients should be considered for clinical trials.\n\n<question>: ",
  "ChatGPT_response_0": "在治疗晚期癌症时，综合疗法通常包括积极参与的姑息治疗专家、联合使用紫杉醇/铂类药物化疗以及可能加入贝伐单抗。对于没有标准二线化疗方案的患者，应考虑参与临床试验以获得更多治疗选择。",
  "query": "在治疗晚期癌症时，你认为综合疗法包括哪些元素？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗晚期癌症时，你认为综合疗法包括哪些元素？\n\n<reference text>: The palliative care specialist should be actively involved.Palliative taxane/platinum combination chemotherapy with/without bevacizumab is the preferred option.There is currently no standard second-line chemotherapy, and such patients should be considered for clinical trials.\n\n<reply>: ",
  "response": "在治疗晚期癌症时，综合疗法通常包括积极参与的姑息治疗专家、联合使用紫杉醇/铂类药物化疗以及可能加入贝伐单抗。对于没有标准二线化疗方案的患者，应考虑参与临床试验以获得更多治疗选择。"
}